XML 67 R52.htm IDEA: XBRL DOCUMENT v3.22.0.1
INVESTMENT IN REAL ESTATE PROPERTIES - Summarized Financial Information for Enlivant Joint Venture (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Balance Sheet Amounts          
Total assets   $ 5,966,707 $ 5,985,603    
Total liabilities   2,587,177 2,576,375    
Member’s deficit   3,379,530 3,409,228 $ 3,488,460 $ 3,254,747
Income Statement Amounts          
Total revenues   569,545 598,569 661,736  
Other-than-temporary impairment   164,126 0 0  
Loss from unconsolidated joint venture   (192,081) (16,599) (6,796)  
Enlivant Joint Venture          
Income Statement Amounts          
Company’s share of net (loss) income   (17,184) 2,546 6,449  
Basis adjustments   10,771 19,145 13,245  
Other-than-temporary impairment $ 164,100 164,126 0 0  
Loss from unconsolidated joint venture   (192,081) (16,599) (6,796)  
Enlivant Joint Venture          
Balance Sheet Amounts          
Total assets   467,762 490,541    
Total liabilities   822,063 824,410    
Member’s deficit   (354,301) (333,869)    
Income Statement Amounts          
Total revenues   274,693 299,031 312,055  
Operating expenses   265,194 240,331 231,659  
Net (loss) income   (35,276) $ 5,196 $ 13,161  
Funding payments beyond contractual requirements   $ 20,000